Ticker >

Colinz Laboratories share price

Colinz Laboratories Ltd.

BSE: 531210 SECTOR: Pharmaceuticals & Drugs  9895   28   0

41.90
+1.10 (2.70%)
BSE: 29 Feb 04:01 PM

Price Summary

Today's High

₹ 42

Today's Low

₹ 39.5

52 Week High

₹ 44

52 Week Low

₹ 33.35

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

10.56 Cr.

Enterprise Value

5.1 Cr.

No. of Shares

0.25 Cr.

P/E

22.22

P/B

1.22

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  34.29

CASH

5.73 Cr.

DEBT

0.27 Cr.

Promoter Holding

66 %

EPS (TTM)

₹  1.89

Sales Growth

2.75%

ROE

5.78 %

ROCE

7.86%

Profit Growth

34.81 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year2.75%
3 Year-1.8%
5 Year-2.02%

Profit Growth

1 Year34.81%
3 Year51.92%
5 Year14.67%

ROE%

1 Year5.78%
3 Year4.42%
5 Year3.39%

ROCE %

1 Year7.86%
3 Year6.3%
5 Year5.13%

Debt/Equity

0.0336

Price to Cash Flow

26.2

Interest Cover Ratio

12.4684512428298

CFO/PAT (5 Yr. Avg.)

2.96445973719698

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 66 0
Sep 2023 66 0
Jun 2023 66 0
Mar 2023 66 0
Dec 2022 66 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 0.2111 Cr.
  • Company is virtually debt free.
  • Company’s PEG ratio is 0.247715211203381.
  • The company has an efficient Cash Conversion Cycle of 17.3409098345403 days.
  • Company has a healthy liquidity position with current ratio of 4.15423360373257.
  • The company has a good cash flow management; CFO/PAT stands at 2.96445973719698.
  • The company has a high promoter holding of 66%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.10871438515524.

 Limitations

  • The company has shown a poor revenue growth of -1.80126910370672% for the Past 3 years.
  • Company has a poor ROE of 4.41640707816532% over the past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 1.68 1.72 1.9 1.79 1.71
Total Expenditure 1.54 1.56 1.75 1.66 1.57
Operating Profit 0.14 0.16 0.15 0.13 0.14
Other Income 0.04 0.04 0.04 0.08 0.05
Interest 0.01 0.01 0.01 0.01 0.01
Depreciation 0.03 0.03 0.03 0.03 0.03
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.13 0.16 0.15 0.16 0.15
Tax 0.03 0.03 0.03 0.04 0.04
Profit After Tax 0.1 0.13 0.12 0.12 0.11
Adjusted EPS (Rs) 0.41 0.5 0.48 0.48 0.42

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 7.58 7.54 6.11 6.95 7.14
Total Expenditure 7.23 7.23 5.78 6.36 6.53
Operating Profit 0.35 0.3 0.33 0.59 0.61
Other Income 0.12 0.13 0.19 0.17 0.17
Interest 0.1 0.07 0.09 0.08 0.05
Depreciation 0.22 0.19 0.19 0.2 0.13
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.16 0.18 0.25 0.48 0.6
Tax 0.03 0.05 0.04 0.14 0.14
Net Profit 0.12 0.13 0.21 0.34 0.46
Adjusted EPS (Rs.) 0.34 0.37 0.59 0.96 1.82

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 3.54 3.54 3.55 3.55 2.52
Total Reserves 3.3 3.29 3.75 4.14 5.62
Borrowings 0 0 0 0 0
Other N/C liabilities 0.55 0.37 0.23 0.26 0.21
Current liabilities 1.79 1.61 2.59 1.98 1.89
Total Liabilities 9.17 8.81 10.1 9.93 10.23
Assets
Net Block 2.21 2.06 2.03 1.86 1.71
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0.5 0.36 0.61 0.67 0.66
Loans & Advances 0.83 0.55 0.2 0.02 0.02
Other N/C Assets 0 0 0 0 0
Current Assets 5.64 5.84 7.27 7.38 7.84
Total Assets 9.17 8.81 10.1 9.93 10.23
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 0.16 0.18 0.25 0.48 0.6
Adjustment 0.19 0.13 0.11 0.11 0.03
Changes in Assets & Liabilities -0.21 0.34 1.88 0.03 -0.07
Tax Paid -0.03 -0.07 -0.08 -0.15 -0.16
Operating Cash Flow 0.12 0.58 2.16 0.47 0.4
Investing Cash Flow -0.01 -0.04 -0.15 -0.03 0.01
Financing Cash Flow 0.02 0.06 0.08 0.09 0.11
Net Cash Flow 0.12 0.6 2.08 0.52 0.52

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 66.00 66.00 66.00 66.00 66.00
a ravi kumar 0.12 0.12 0.12 0.12 0.12
a.k. chaterjee 0.08 0.08 0.08 0.08 0.08
a.n. ansari 0.12 0.12 0.12 0.12 0.12
a.p.rehman 0.12 0.12 0.12 0.12 0.12
abdul azeez 0.12 0.12 0.12 0.12 0.12
amrut b kothari 0.12 0.12 0.12 0.12 0.12
anoop bhat 0.08 0.08 0.08 0.08 0.08
ashok k nigam 0.12 0.12 0.12 0.12 0.12
ashok lobo 0.12 0.12 0.12 0.12 0.12
ashok p. chaturvedi 0.12 0.12 0.12 0.12 0.12
asit sengupta 0.08 0.08 0.08 0.08 0.08
atul gopalakrishnan 0.12 0.12 0.12 0.12 0.12
bachubhai r. vora 0.08 0.08 0.08 0.08 0.08
binoy mukerjee 0.12 0.12 0.12 0.12 0.12
c h jalan 0.08 0.08 0.08 0.08 0.08
c.k. ramesh, md 0.12 0.12 0.12 0.12 0.12
chinmay de 0.08 0.08 0.08 0.08 0.08
d s ahuluwalia 0.08 0.08 0.08 0.08 0.08
deepak k shah 0.40 0.40 0.40 0.40 0.40
devendra k punatar 0.08 0.08 0.08 0.08 0.08
dilip s. malvankar 0.12 0.12 0.12 0.12 0.12
edwin fernandez 0.08 0.08 0.08 0.08 0.08
elvy jacob 0.12 0.12 0.12 0.12 0.12
g g prabhu 0.12 0.12 0.12 0.12 0.12
g.m. mansukhani 0.08 0.08 0.08 0.08 0.08
girija narayanan 0.12 0.12 0.12 0.12 0.12
harendra a mehta 0.20 0.20 0.20 0.20 0.20
hari krishna prasad 0.12 0.12 0.12 0.12 0.12
hariram k. yadav 0.12 0.12 0.12 0.12 0.12
hemant n. sar desai 0.12 0.12 0.12 0.12 0.12
indu s batra 0.08 0.08 0.08 0.08 0.08
jacob rajan 0.12 0.12 0.12 0.12 0.12
jagdish kumar oswal 0.12 0.12 0.12 0.12 0.12
jayant s. thakkar 0.08 0.08 0.08 0.08 0.08
jayaprakash shetty m 0.12 0.12 0.12 0.12 0.12
k gopinath 0.12 0.12 0.12 0.12 0.12
k k bhargava 0.12 0.12 0.12 0.12 0.12
k k chaterjee 0.08 0.08 0.08 0.08 0.08
k k cheriyan 0.12 0.12 0.12 0.12 0.12
k kanakarajan 0.12 0.12 0.12 0.12 0.12
k krishnan kutty 0.12 0.12 0.12 0.12 0.12
k p achuthan 0.12 0.12 0.12 0.12 0.12
k periyaswmay 0.12 0.12 0.12 0.12 0.12
k ramanna shetty 0.08 0.08 0.08 0.08 0.08
k s krishnan 0.12 0.12 0.12 0.12 0.12
k s subramanian 0.01 0.01 0.01 0.01 0.01
k s yugandhar 0.12 0.12 0.12 0.12 0.12
k.r.krishna murthy 0.12 0.12 0.12 0.12 0.12
karim m khan 0.12 0.12 0.12 0.12 0.12
kaushik k.g. md. dgo 0.12 0.12 0.12 0.12 0.12
kiran ramanlal joshi 0.08 0.08 0.08 0.08 0.08
krishnamurthy g ayya 0.08 0.08 0.08 0.08 0.08
lakshmi kalyanaraman 0.08 0.08 0.08 0.08 0.08
lilit kumar chordia 0.12 0.12 0.12 0.12 0.12
m babu 0.12 0.12 0.12 0.12 0.12
m ranganath pai 0.06 0.06 0.06 0.06 0.06
m venugopal 0.12 0.12 0.12 0.12 0.12
manakini r.desai 0.12 0.12 0.12 0.12 0.12
mani l s 34.45 34.45 34.45 34.45 34.45
manubhai m patel 0.24 0.24 0.24 0.24 0.24
mercy vincent 0.12 0.12 0.12 0.12 0.12
milind d. godbole 0.12 0.12 0.12 0.12 0.12
mohan s. pinto 0.08 0.08 0.08 0.08 0.08
muraleevardhanam 0.12 0.12 0.12 0.12 0.12
n narayanan 0.12 0.12 0.12 0.12 0.12
n s santosh kumar 0.12 0.12 0.12 0.12 0.12
n.h. chandrasekhar 0.12 0.12 0.12 0.12 0.12
n.k. acharya 0.12 0.12 0.12 0.12 0.12
narinder k khosla 0.08 0.08 0.08 0.08 0.08
navinchandra n shah 0.08 0.08 0.08 0.08 0.08
nitin s pednekar 0.12 0.12 0.12 0.12 0.12
o p agarwal 0.12 0.12 0.12 0.12 0.12
omprakash tiwari 0.08 0.08 0.08 0.08 0.08
p ramachandran 0.12 0.12 0.12 0.12 0.12
p subramanian 0.12 0.12 0.12 0.12 0.12
p suresh 0.12 0.12 0.12 0.12 0.12
p venketeswaralu 0.12 0.12 0.12 0.12 0.12
p. nageshwar rao 0.12 0.12 0.12 0.12 0.12
p.p. balakrishnan 0.12 0.12 0.12 0.12 0.12
p.r. kulkarni 0.12 0.12 0.12 0.12 0.12
poonam r bidani 0.08 0.08 0.08 0.08 0.08
prakash rao 0.12 0.12 0.12 0.12 0.12
pramod j rao 0.08 0.08 0.08 0.08 0.08
prasanna p.hegde 0.12 0.12 0.12 0.12 0.12
pravinchand kuverji shah 0.08 0.08 0.08 0.08 0.08
preethi ganapati 0.08 0.08 0.08 0.08 0.08
prem prakash mehra 0.08 0.08 0.08 0.08 0.08
r gunasekharan 0.12 0.12 0.12 0.12 0.12
r k jalan 0.12 0.12 0.12 0.12 0.12
r mohammed 0.12 0.12 0.12 0.12 0.12
r p malhotra 0.12 0.12 0.12 0.12 0.12
r premchandran 0.12 0.12 0.12 0.12 0.12
r v nathan 0.08 0.08 0.08 0.08 0.08
rahul m anthony 0.12 0.12 0.12 0.12 0.12
rajeev .k. goyal 0.12 0.12 0.12 0.12 0.12
rajendra shamji pankhania... 0.12 0.12 0.12 0.12 0.12
rajesh chandran 0.12 0.12 0.12 0.12 0.12
ramanlal n. gupta 0.08 0.08 0.08 0.08 0.08
ramesh jain 0.08 0.08 0.08 0.08 0.08
ramesh khati 0.05 0.05 0.05 0.05 0.05
ramesh thakkur 0.12 0.12 0.12 0.12 0.12
ravi k agarwal 0.08 0.08 0.08 0.08 0.08
ravi n menon 0.12 0.12 0.12 0.12 0.12
s k paliwal 0.12 0.12 0.12 0.12 0.12
s k sundaram 0.12 0.12 0.12 0.12 0.12
s p ajithkumar 0.12 0.12 0.12 0.12 0.12
s s goyal 0.12 0.12 0.12 0.12 0.12
s. jaya raman m.s. 0.12 0.12 0.12 0.12 0.12
s. srinivasa rao 0.08 0.08 0.08 0.08 0.08
s.b. kadam 0.12 0.12 0.12 0.12 0.12
sanjay g. seth 0.12 0.12 0.12 0.12 0.12
sanjay lahoti 0.12 0.12 0.12 0.12 0.12
sanjay s apte 0.12 0.12 0.12 0.12 0.12
sanjiv sood 0.08 0.08 0.08 0.08 0.08
sashikant r. jaguste 0.08 0.08 0.08 0.08 0.08
satya prakash shukla 0.08 0.08 0.08 0.08 0.08
seethalakshmy krishnan 0.08 0.08 0.08 0.08 0.08
shailendra r bhandari 0.04 0.04 0.04 0.04 0.04
shailendra rambilas bhand... 0.04 0.04 0.04 0.04 0.04
shanti kumar das 0.08 0.08 0.08 0.08 0.08
sheetal j shah 0.16 0.16 0.16 0.16 0.16
shobha patil 0.12 0.12 0.12 0.12 0.12
shobhana s kulkarni 0.08 0.08 0.08 0.08 0.08
shyam singh tripathi 0.12 0.12 0.12 0.12 0.12
siva prasad rao 0.12 0.12 0.12 0.12 0.12
sony thomas 0.12 0.12 0.12 0.12 0.12
sridhar reddy 0.12 0.12 0.12 0.12 0.12
sudhir k. deshpande 0.12 0.12 0.12 0.12 0.12
sujatha sadanand bhat 0.07 0.07 0.07 0.07 0.07
sunil rajnikant chougule 0.08 0.08 0.08 0.08 0.08
sunil s. verma 0.12 0.12 0.12 0.12 0.12
suresh k batra 0.08 0.08 0.08 0.08 0.08
suresh k singh 0.12 0.12 0.12 0.12 0.12
t hariharan 0.12 0.12 0.12 0.12 0.12
t n krishna swamy 0.12 0.12 0.12 0.12 0.12
t rajendran 0.12 0.12 0.12 0.12 0.12
t. s. arora 0.08 0.08 0.08 0.08 0.08
t.p. khajabhoman 0.12 0.12 0.12 0.12 0.12
t.s. devaki 0.12 0.12 0.12 0.12 0.12
t.s. janardhan 0.12 0.12 0.12 0.12 0.12
uma muthappa 0.12 0.12 0.12 0.12 0.12
unni namboodiri 0.12 0.12 0.12 0.12 0.12
usha h mehta 0.20 0.20 0.20 0.20 0.20
v. k. jain 0.12 0.12 0.12 0.12 0.12
vijay n. pawar 0.12 0.12 0.12 0.12 0.12
vijaya mani 15.11 15.11 15.11 15.11 15.11
vinod k tiwari 0.12 0.12 0.12 0.12 0.12
vinod kumar saxena m.s 0.12 0.12 0.12 0.12 0.12
vishwanath p naidu 0.12 0.12 0.12 0.12 0.12
vittal r.shenoy 0.12 0.12 0.12 0.12 0.12
y.p. tribhuvan 0.12 0.12 0.12 0.12 0.12
y.s. bhatnagar m.s. 0.12 0.12 0.12 0.12 0.12
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 34.00 34.00 34.00 34.00 34.00
dipakbhai haribhai gaudan... 1.31 1.31 1.31 1.31 1.31
rasilaben dipakbhai gauda... 1.23 1.23 1.23 1.23 1.23

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Colinz Laboratories informs about press release1 Feb 2024, 2:45PM Colinz Laboratories - Quaterly Results31 Jan 2024, 5:48PM Colinz Laboratories - Quaterly Results31 Jan 2024, 5:48PM Colinz Laboratories - Quaterly Results31 Jan 2024, 5:48PM Colinz Laboratories - Quaterly Results31 Oct 2023, 5:15PM Colinz Laboratories - Quaterly Results31 Oct 2023, 5:15PM Colinz Laboratories - Quaterly Results31 Oct 2023, 5:15PM Colinz Laboratories - Quaterly Results31 Jul 2023, 5:45PM Colinz Laboratories - Quaterly Results31 Jul 2023, 5:45PM Colinz Laboratories - Quaterly Results31 Jul 2023, 5:45PM Colinz Laboratories submits board meeting intimation14 Jul 2023, 1:00PM Colinz Laboratories informs about annual secretarial compliance report2 May 2023, 5:11PM Colinz Laboratories - Quaterly Results28 Jan 2023, 4:45PM Colinz Laboratories - Quaterly Results28 Jan 2023, 4:45PM Colinz Laboratories - Quaterly Results28 Jan 2023, 4:45PM Colinz Laboratories - Quaterly Results31 Oct 2022, 5:30PM Colinz Laboratories - Quaterly Results31 Oct 2022, 5:30PM Colinz Laboratories - Quaterly Results31 Oct 2022, 5:30PM Colinz Laboratories informs about compliances-certificate10 Oct 2022, 4:22PM Colinz Laboratories - Quaterly Results30 Jul 2022, 5:34PM Colinz Laboratories - Quaterly Results30 Jul 2022, 5:34PM Colinz Laboratories - Quaterly Results30 Jul 2022, 5:34PM Colinz Laboratories informs about certificate12 Apr 2022, 3:16PM Colinz Laboratories - Quaterly Results31 Jan 2022, 4:45PM Colinz Laboratories - Quaterly Results31 Jan 2022, 4:45PM Colinz Laboratories informs about compliance certificate 24 May 2021, 3:19PM

Colinz Laboratories Stock Price Analysis and Quick Research Report. Is Colinz Laboratories an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Colinz Laboratories and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Colinz Laboratories cash from the operating activity was Rs 0.4029 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Colinz Laboratories has a Debt to Equity ratio of 0.0336 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Colinz Laboratories , the EPS growth was 89.7084944101975 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Colinz Laboratories has OPM of 8.53183499607666 % which is a bad sign for profitability.
     
  • ROE: Colinz Laboratories have a poor ROE of 5.78014229209053 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Colinz Laboratories is Rs 41.9. One can use valuation calculators of ticker to know if Colinz Laboratories share price is undervalued or overvalued.
Last Updated on:
Brief about Colinz Laboratories
X